Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$11.86 - $21.77 $992,112 - $1.82 Million
-83,652 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$7.25 - $11.76 $35,380 - $57,388
4,880 Added 6.2%
83,652 $965,000
Q3 2020

Nov 16, 2020

BUY
$6.53 - $8.6 $514,381 - $677,439
78,772 New
78,772 $600,000
Q2 2019

Aug 14, 2019

SELL
$3.43 - $5.6 $109,351 - $178,533
-31,881 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$3.56 - $4.82 $41,915 - $56,750
11,774 Added 58.56%
31,881 $135,000
Q4 2018

Feb 14, 2019

BUY
$4.04 - $6.75 $28,207 - $47,128
6,982 Added 53.2%
20,107 $82,000
Q3 2018

Nov 14, 2018

SELL
$4.28 - $7.32 $11,859 - $20,283
-2,771 Reduced 17.43%
13,125 $90,000
Q2 2018

Aug 14, 2018

BUY
$3.1 - $3.93 $49,277 - $62,471
15,896 New
15,896 $62,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $461M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Zebra Capital Management LLC Portfolio

Follow Zebra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zebra Capital Management LLC with notifications on news.